Abstract
Essential oils are the volatile fraction of aromatic and medicinal plants after extraction by steam or water distillation. They have been used for their pharmaceutical potential since early times, and even now are still subject to a great deal of attention, as is clear from the increasing number of publications each year on this subject. This review presents both fundamental and recent studies concerned with the role of Nigella species essential oils and their major constituents, thymoquinone and β-elemene, as potential chemotherapeutic and chemopreventive anti-cancer agents. The mechanism of action and the factors which determine the concentrations of these major constituents in the essential oil are also reviewed.
Keywords: Anti-cancer, essential oils, Nigella sativa, Nigella damascene, thymoquinone, β-elemene
Current Clinical Pharmacology
Title: Anti-Cancer Properties of Nigella spp. Essential Oils and their Major Constituents, Thymoquinone and β-Elemene
Volume: 4 Issue: 1
Author(s): Amr E. Edris
Affiliation:
Keywords: Anti-cancer, essential oils, Nigella sativa, Nigella damascene, thymoquinone, β-elemene
Abstract: Essential oils are the volatile fraction of aromatic and medicinal plants after extraction by steam or water distillation. They have been used for their pharmaceutical potential since early times, and even now are still subject to a great deal of attention, as is clear from the increasing number of publications each year on this subject. This review presents both fundamental and recent studies concerned with the role of Nigella species essential oils and their major constituents, thymoquinone and β-elemene, as potential chemotherapeutic and chemopreventive anti-cancer agents. The mechanism of action and the factors which determine the concentrations of these major constituents in the essential oil are also reviewed.
Export Options
About this article
Cite this article as:
Edris E. Amr, Anti-Cancer Properties of Nigella spp. Essential Oils and their Major Constituents, Thymoquinone and β-Elemene, Current Clinical Pharmacology 2009; 4(1) . https://dx.doi.org/10.2174/157488409787236137
DOI https://dx.doi.org/10.2174/157488409787236137 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
p53 Regulation of Energy Metabolism and Mitochondria Regulation of p53 in Cancer Cells: An Insight into the Role of Manganese Superoxide Dismutase
Current Pharmaceutical Biotechnology Physiological and Non-Redundant Functions of PKC Isotypes in T Lymphocytes
Current Immunology Reviews (Discontinued) Gene Regulation in Cancer Gene Therapy Strategies
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Drug Delivery DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design Nucleic-Acid Delivery Using Lipid Nanocapsules
Current Pharmaceutical Biotechnology The Design of Amphiphilic Polymeric Micelles of Curcumin for Cancer Management
Current Medicinal Chemistry A Transporter Gene (Sodium Iodide Symporter) for Dual Purposes in Gene Therapy: Imaging and Therapy
Current Gene Therapy Pore-forming Peptides: A New Treatment Option for Cancer
Current Medicinal Chemistry Oncogenic LncRNA CASC9 in Cancer Progression
Current Pharmaceutical Design Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets
Current Molecular Pharmacology The Challenge of microRNA as a Biomarker of Epilepsy
Current Neuropharmacology Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Current Drug Targets Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Current Medicinal Chemistry Nanoparticle-Derived Non-Viral Genetic Transfection at the Blood-Brain Barrier to Enable Neuronal Growth Factor Delivery by Secretion from Brain Endothelium
Current Medicinal Chemistry Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention
Current Medicinal Chemistry Signal Transduction Pathways of Taxanes-Induced Apoptosis
Current Medicinal Chemistry - Anti-Cancer Agents Triazene Compounds in the Treatment of Acute Myeloid Leukemia: A Short Review and a Case Report
Current Medicinal Chemistry Flavonoids: The Innocuous Agents Offering Protection against Alzheimer’s Disease Through Modulation of Proinflammatory and Apoptotic Pathways
Current Topics in Medicinal Chemistry